Myomo Inc
Suletud
0.82 -5.75
Ülevaade
Aktsiahinna muutus
24h
Min
0.79
Max
0.93
Sissetulek | -151K -3.8M |
|---|---|
Müük | 1.3M 11M |
Kasumimarginaal | -33.593 |
Töötajad | 194 |
EBITDA | 763K -2.3M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +396.55% upside |
Turukapital | 4.5M 33M |
|---|---|
Eelmine avamishind | 6.57 |
Eelmine sulgemishind | 0.82 |
Myomo Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Myomo Inc Prognoos
Hinnasiht
By TipRanks
396.55% tõus
12 kuu keskmine prognoos
Keskmine 4.32 USD 396.55%
Kõrge 9.5 USD
Madal 1.1 USD
Põhineb 5 Wall Streeti analüütiku instrumendi Myomo Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
